Lidia Gil

3.3k total citations
136 papers, 1.2k citations indexed

About

Lidia Gil is a scholar working on Hematology, Oncology and Epidemiology. According to data from OpenAlex, Lidia Gil has authored 136 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Hematology, 49 papers in Oncology and 27 papers in Epidemiology. Recurrent topics in Lidia Gil's work include Hematopoietic Stem Cell Transplantation (21 papers), Acute Myeloid Leukemia Research (16 papers) and Lymphoma Diagnosis and Treatment (16 papers). Lidia Gil is often cited by papers focused on Hematopoietic Stem Cell Transplantation (21 papers), Acute Myeloid Leukemia Research (16 papers) and Lymphoma Diagnosis and Treatment (16 papers). Lidia Gil collaborates with scholars based in Poland, Spain and United States. Lidia Gil's co-authors include Mieczysław Komarnicki, Jan Styczyński, Joanna Rupa‐Matysek, Per Ljungman, Hermann Einsele, Maciej Kaźmierczak, Dominik Dytfeld, Elżbieta Nowakowska, Katarzyna Brzeźniakiewicz‐Janus and Anna Olewicz‐Gawlik and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Science of The Total Environment.

In The Last Decade

Lidia Gil

115 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lidia Gil Poland 17 414 413 269 244 192 136 1.2k
Netanel A. Horowitz Israel 17 215 0.5× 429 1.0× 154 0.6× 108 0.4× 229 1.2× 77 1.0k
Martin Mohren Germany 17 321 0.8× 188 0.5× 170 0.6× 91 0.4× 185 1.0× 37 936
Shayna Sarosiek United States 16 247 0.6× 183 0.4× 363 1.3× 118 0.5× 182 0.9× 109 1.1k
Federica Sorà Italy 18 513 1.2× 296 0.7× 227 0.8× 119 0.5× 110 0.6× 95 1.2k
Panagiotis Tsirigotis Greece 22 767 1.9× 445 1.1× 251 0.9× 188 0.8× 176 0.9× 122 1.6k
Prem Mahendra United Kingdom 9 586 1.4× 313 0.8× 168 0.6× 268 1.1× 236 1.2× 14 1.2k
Cynthia Rutherford United States 18 326 0.8× 264 0.6× 210 0.8× 207 0.8× 201 1.0× 35 1.1k
W. Nürnberger Germany 18 510 1.2× 281 0.7× 138 0.5× 225 0.9× 84 0.4× 58 1.2k
Okke de Weerdt Netherlands 17 627 1.5× 250 0.6× 173 0.6× 124 0.5× 85 0.4× 49 1.1k
Mutlu Arat Türkiye 23 919 2.2× 426 1.0× 282 1.0× 220 0.9× 98 0.5× 128 1.7k

Countries citing papers authored by Lidia Gil

Since Specialization
Citations

This map shows the geographic impact of Lidia Gil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lidia Gil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lidia Gil more than expected).

Fields of papers citing papers by Lidia Gil

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lidia Gil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lidia Gil. The network helps show where Lidia Gil may publish in the future.

Co-authorship network of co-authors of Lidia Gil

This figure shows the co-authorship network connecting the top 25 collaborators of Lidia Gil. A scholar is included among the top collaborators of Lidia Gil based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lidia Gil. Lidia Gil is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Matuszak, Magdalena, et al.. (2023). Emergencies in patients undergoing hematopoietic stem cell transplantation. Acta Haematologica Polonica. 1 indexed citations
3.
Kubicki, Tadeusz, et al.. (2023). G6PD deficiency—does it alter the course of COVID-19 infections?. Annals of Hematology. 102(7). 1629–1636. 3 indexed citations
4.
Rupa‐Matysek, Joanna, et al.. (2023). A Panoramic X-ray as a Supportive Diagnostic Tool for the Screening of Osteoporosis in Patients with Hemophilia A and B. Journal of Clinical Medicine. 12(21). 6901–6901.
5.
Styczyński, Jan, Gloria Tridello, Nina Knelange, et al.. (2023). Prevalence, management, and new treatment modalities of EBV-DNA-emia and EBV-PTLD after allo-HCT: survey of Infectious Diseases Working Party EBMT. Bone Marrow Transplantation. 59(1). 59–65. 2 indexed citations
6.
Szałek, Edyta, et al.. (2023). Midostaurin – the First Targeted Therapy Drug for Patients with Acute Myeloid Leukaemia with FLT3 Mutation. Acta Poloniae Pharmaceutica - Drug Research. 79(6). 777–784. 1 indexed citations
7.
Rupa‐Matysek, Joanna, et al.. (2022). Potential Biochemical Markers and Radiomorphometric Indices as Predictors of Reduced Bone Mass in Patients with Congenital Hemophilia. Journal of Clinical Medicine. 11(12). 3391–3391. 6 indexed citations
8.
9.
Kołodziejczak, Michalina, et al.. (2021). Impact of donor and recipient Epstein-Barr Virus serostatus on outcomes of allogeneic hematopoietic cell transplantation: a systematic review and meta-analysis. Annals of Hematology. 100(3). 763–777. 9 indexed citations
10.
Kozijn, A.E., Katerina Bakunina, Diana Averbuch, et al.. (2021). Contribution of nurses to protective environment in haematopoietic cell transplant setting: an international survey by the European Society for Blood and Marrow Transplantation. Bone Marrow Transplantation. 56(6). 1433–1440. 5 indexed citations
11.
Styczyński, Jan, Simone Cesaro, Marie von Lilienfeld‐Toal, et al.. (2021). Current attitude to deferral of cellular therapy or nontransplant chemotherapy due to SARS‐CoV‐2 asymptomatic infection: Survey of Infectious Diseases Working Party EBMT. Transplant Infectious Disease. 24(2). e13773–e13773. 1 indexed citations
12.
13.
Brzeźniakiewicz‐Janus, Katarzyna, et al.. (2020). Selected Hematological Biomarkers to Predict Acute Mortality in Emergency Department Patients. Recent Polish Hospital Statistics. Disease Markers. 2020. 1–10. 6 indexed citations
14.
Brzeźniakiewicz‐Janus, Katarzyna, et al.. (2019). Clinical Profiles of Selected Biomarkers Identifying Infection and Cancer Patients: A Gorzów Hospital Example. Disease Markers. 2019. 1–8. 2 indexed citations
15.
Brzeźniakiewicz‐Janus, Katarzyna, et al.. (2019). Is Migraine an MPV-Related Disease? An Observational Study of Polish Neurological Patients. Disease Markers. 2019. 1–7. 2 indexed citations
16.
Gil, Lidia, et al.. (2017). Isolated myeloid sarcoma as the first manifestation of acute myeloid leukemia: a case study. Clinical Case Reports. 5(11). 1802–1806. 4 indexed citations
17.
Gil, Lidia. (2011). Allogeniczne przeszczepienie krwiotwórczych komórek macierzystych w leczeniu chorych z ostrą białaczką szpikową. Via Medica Journals. 1 indexed citations
18.
Gil, Lidia, et al.. (2009). Diagnostic and treatment strategy of invasive aspergillosis based on galactomannan screenning – prospective analysis of 268 patients after hematopoietic stem cell transplantation. Annals of Transplantation. 14(1). 21–22. 1 indexed citations
19.
Gil, Lidia, Jan Styczyński, Dominik Dytfeld, et al.. (2008). Activity of bortezomib in adult de novo and relapsed acute myeloid leukemia.. PubMed. 27(6B). 4021–5. 20 indexed citations
20.
Gil, Lidia, et al.. (2008). Rituximab in haematology and oncology in 10 years of experience. Contemporary Oncology/Współczesna Onkologia. 12(4). 173–178. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Netanel A. Horowitz Breakdown of academic impact, for papers by Martin Mohren Breakdown of academic impact, for papers by Shayna Sarosiek Breakdown of academic impact, for papers by Federica Sorà Breakdown of academic impact, for papers by Panagiotis Tsirigotis Breakdown of academic impact, for papers by Prem Mahendra Breakdown of academic impact, for papers by Cynthia Rutherford Breakdown of academic impact, for papers by W. Nürnberger Breakdown of academic impact, for papers by Okke de Weerdt Breakdown of academic impact, for papers by Mutlu Arat
Rankless by CCL
2026